https://www.selleckchem.com/pe....ptide/bulevirtide-my
BACKGROUND Patients with peripheral artery disease and associated intermittent claudication can experience significant short-term (for instance, day-to-day) variations in their walking ability. This variability is often viewed as a complication in establishing reliable baseline walking performance levels for individual patients in multi-patient supervised walking programs. METHODS In contrast, the present five-month-long quantified community walking program deliberately focuses on the variability referred to above, search
Like
Comment
Share
